ArisGlobal Launches LifeSphere Publishing as Key Component of LifeSphere Regulatory Cloud Platform
MIAMI, March 7, 2019 /PRNewswire/ -- ArisGlobal, a leading provider of life sciences software that automates core drug development functions...
News
Welltok’s Tea Leaves Health Launches New Enterprise Growth Solution
DENVER, March 7, 2019 /PRNewswire/ -- More than ever, the consumer is at the center of today's leading health system growth...
Ravenswood and GDM Announce Strategic Partnership
FREMONT, Calif. and SAN JOSE, Calif., March 6, 2019 /PRNewswire/ -- Ravenswood Solutions, Inc., a leading provider of turnkey military training...
elminda and RI.Group to Form RI.Mind – a Joint Venture to Apply elminda’s Brain Analytics Technology for Personalization of Medical Cannabis
HERZLIYA, Israel, March 7, 2019 /PRNewswire/ -- elminda Ltd., a leading brain technology company, and RI.Group Investment Management Ltd., a...
Qure.ai Taps Former GE Healthcare Exec as Chief Commercial Officer
NEW YORK, March 7, 2019 /PRNewswire/ -- Qure.ai (http://www.qure.ai), a leading healthcare AI company, today announced Chiranjiv Singh has joined...
Elsevier Launches Assessment Capabilities on Its All-new ClinicalKey Student Platform
LONDON, March 7, 2019 /PRNewswire/ -- ClinicalKey Student equips medical faculty and students with the resources they need to enhance...
Stormont Vail Health Partners with Omnicell to Enhance Medication Management Strategy
MOUNTAIN VIEW, Calif., March 7, 2019 /PRNewswire/ -- Omnicell, Inc. (NASDAQ: OMCL) today announced that Stormont Vail Health has selected Omnicell's...
Kelyniam Announces 2018 Financial Results
COLLINSVILLE, Conn., March 7, 2019 /PRNewswire/ -- Kelyniam Global, Inc., (OTC: KLYG), a manufacturer of custom cranial implants has issued a...
CorMedix Inc. to Present at Roth and Oppenheimer & Co. Investor Conferences
BERKELEY HEIGHTS, NJ / ACCESSWIRE / March 11, 2019 / CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on...
ENDRA Life Sciences Reports Full Year 2018 Financial & Operational Results
Management to Host Full Year 2018 Conference Call Today at 4:30 p.m. ET ANN ARBOR, MI / ACCESSWIRE / March...
Easton Commences Cannabis Edibles Division and Announces Updates on Its Filing for the Period Ended December 31, 2018
TORONTO, ON / ACCESSWIRE / March 11, 2019 / Easton Pharmaceuticals Inc. (OTC PINK: EAPH) announces that it has commenced...
Cerecor Announces Closing of $10.0 Million Bought Deal of Common Stock
ROCKVILLE, MD / ACCCESSWIRE / March 11, 2019 / Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a...
Viveve Completes Enrollment in VIVEVE II Trial
Results could support a marketing application for an expanded U.S. indication for improvement of sexual function in women ENGLEWOOD, CO...
IntraBio Clinical Trial Authorisation Application Approved by the MHRA for the treatment of Niemann-Pick Disease Type C
OXFORD, UK / ACCESSWIRE / March 11, 2019 / IntraBio Inc., a late-stage biopharmaceutical company, today announced that the UK...
ORYZON Announces FDA Approval of IND for ETHERAL, a Phase IIa trial of the Epigenetic Drug Vafidemstat in Patients with Mild to Moderate Alzheimer’s disease
Recruitment is ongoing in Europe; The European and US Study will recruit a total of 150 patients MADRID, SPAIN and...
Nevada Hemp Licence Acquired
VANCOUVER, BC / ACCESSWIRE / March 11, 2019 / EVITRADE Health Systems Corp. (CSE: EVA, OTCQB: EVAHF) (the "Company") is...
Dr. Michael Lange’s Fortifeye Vitamins Announces Advanced Dry Eye Therapy – Sold Out In Just Three Weeks
OCALA, FL / ACCESSWIRE / March 8, 2019 / Fortifeye Vitamins announced today that its Advanced Dry Eye Therapy, which...
Paris Fashion Week – LIU CHAO 2019FW: Esprit Couture
NEW YORK, NY / ACCESSWIRE / March 8, 2019 / The young Chinese Paris - Based designer, Liu Chao, will...
NanoVibronix CEO to Present UroShield(R) at the U.S. National Institutes of Health’s Catheter-Associated Urinary Tract Infections Technology Workshop
ELMSFORD, NY / ACCESSWIRE / March 8, 2019 / NanoVibronix, Inc. (NASDAQ: NAOV), a medical device company utilizing its proprietary...
Soliton’s RAP Device Received Institutional Review Board Approval of Non-Significant Risk Designation
HOUSTON, TX / ACCESSWIRE / March 8, 2019 / Soliton, Inc., (NASDAQ: SOLY) ("Soliton" or the "Company"), a medical device...